ROBERT H. WILLIAMS, M.D., F.A.C.P.; WILLIAM H. DAUGHADAY, M.D.; WALTER F. ROGERS JR., M.D.; SAMUEL P. ASPER JR., M.D.; BEVERLY T. TOWERY, M.D.
This content is PDF only. Please click on the PDF icon to access.
In spite of the frequent enlightening discussions in social and scientific circles on factors contributing to the development of obesity and on the treatment of this condition, there continues to be a vast number of markedly obese individuals. The deleterious effects produced by this condition, directly or indirectly, are much greater than seems to be generally recognized. In addition to the social and occupational handicaps and associated mental distress which obesity causes, it predisposes to the development of cardiovascular diseases and diabetes mellitus. Marked obesity exerts a pronounced effect on life expectancy. For example, Dublin and Lotka1 found that individuals
WILLIAMS RH, DAUGHADAY WH, ROGERS WF, et al. OBESITY AND ITS TREATMENT, WITH PARTICULAR REFERENCE TO THE USE OF ANOREXIGENIC COMPOUNDS*. Ann Intern Med. 1948;29:510–532. doi: https://doi.org/10.7326/0003-4819-29-3-510
Download citation file:
Published: Ann Intern Med. 1948;29(3):510-532.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use